Bahram Pourghassem Gargari1, Nazli Namazi2, Mohammad Khalili3, Bahareh Sarmadi4, Mohammad Asghari Jafarabadi5, Parvin Dehghan6. 1. Department of biochemistry & Nutrition, Faculty of Nutrition, Tabriz University of Medical Sciences, Tabriz, Iran. 2. Faculty of Nutrition, Nutrition Research Center, Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran. 3. Neurosciences Research Center Tabriz University of Medical Sciences, Tabriz, Iran. 4. Department of Nutrition and Dietetics, Faculty of Medicine and Health Sciences, University Putra Malaysia, 43400 Serdang, Selangor, Malaysia. 5. Traffic Injury Prevention Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. 6. Faculty of Nutrition, Nutrition Research Center, Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: dehghan.nut@gmail.com.
Abstract
OBJECTIVE: The aim of the present study was to determine effects of Resistant Starch (RS2) on metabolic parameters and inflammation in women with type 2 diabetes (T2DM). METHODS: In this randomized controlled clinical trial, 60 females with T2DM were divided into intervention (n = 28) and placebo groups (n = 32). They received 10 g/d RS2 or placebo for 8 weeks, respectively. Fasting blood sugar (FBS), glycated hemoglobin (HbA1c), lipid profile, high-sensitive C-reactive protein (hs-CRP), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) were measured at baseline and at the end of the trial. Paired t test, unpaired t-test and ANCOVA were used to compare the quantitative variables. The data were analyzed using SPSS software version 13.0. RESULTS:RS2 decreased HbA1c (-0.3%, -3.6%), TNF-α (-3.4 pg/mL, -18.9%), triglyceride (-33.4 mg/dL, -15.4%), and it increased HDL-c (+9.4 mg/dL, +24.6%) significantly compared with the placebo group (p < 0.05). Changes in FBS, total cholesterol, low-density lipoprotein, hs-CRP and IL-6 were not significant in the RS2 group compared with the control group. RS2 can improve glycemic status, inflammatory markers and lipid profile in women with T2DM. CONCLUSIONS: Although findings of the present study indicated positive effects of RS2 on inflammation and metabolic parameters, more studies are needed to confirm efficacy of RS2 as an adjunct therapy in diabetes.
RCT Entities:
OBJECTIVE: The aim of the present study was to determine effects of Resistant Starch (RS2) on metabolic parameters and inflammation in women with type 2 diabetes (T2DM). METHODS: In this randomized controlled clinical trial, 60 females with T2DM were divided into intervention (n = 28) and placebo groups (n = 32). They received 10 g/d RS2 or placebo for 8 weeks, respectively. Fasting blood sugar (FBS), glycated hemoglobin (HbA1c), lipid profile, high-sensitive C-reactive protein (hs-CRP), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) were measured at baseline and at the end of the trial. Paired t test, unpaired t-test and ANCOVA were used to compare the quantitative variables. The data were analyzed using SPSS software version 13.0. RESULTS:RS2 decreased HbA1c (-0.3%, -3.6%), TNF-α (-3.4 pg/mL, -18.9%), triglyceride (-33.4 mg/dL, -15.4%), and it increased HDL-c (+9.4 mg/dL, +24.6%) significantly compared with the placebo group (p < 0.05). Changes in FBS, total cholesterol, low-density lipoprotein, hs-CRP and IL-6 were not significant in the RS2 group compared with the control group. RS2 can improve glycemic status, inflammatory markers and lipid profile in women with T2DM. CONCLUSIONS: Although findings of the present study indicated positive effects of RS2 on inflammation and metabolic parameters, more studies are needed to confirm efficacy of RS2 as an adjunct therapy in diabetes.
Authors: Ursula White; Courtney M Peterson; Robbie A Beyl; Corby K Martin; Eric Ravussin Journal: J Acad Nutr Diet Date: 2020-04-09 Impact factor: 4.910
Authors: Courtney M Peterson; Robbie A Beyl; Kara L Marlatt; Corby K Martin; Kayanush J Aryana; Maria L Marco; Roy J Martin; Michael J Keenan; Eric Ravussin Journal: Am J Clin Nutr Date: 2018-09-01 Impact factor: 7.045
Authors: Zahra Lotfollahi; Ana Paula de Queiroz Mello; Edna S Costa; Cristiano L P Oliveira; Nagila R T Damasceno; Maria Cristina Izar; Antonio Martins Figueiredo Neto Journal: Sci Rep Date: 2020-07-23 Impact factor: 4.379
Authors: Denisa Margină; Anca Ungurianu; Carmen Purdel; George Mihai Nițulescu; Dimitris Tsoukalas; Evangelia Sarandi; Maria Thanasoula; Tatyana I Burykina; Fotis Tekos; Aleksandra Buha; Dragana Nikitovic; Demetrios Kouretas; Aristidis Michael Tsatsakis Journal: Food Chem Toxicol Date: 2020-07-05 Impact factor: 6.023
Authors: Denisa Margină; Anca Ungurianu; Carmen Purdel; Dimitris Tsoukalas; Evangelia Sarandi; Maria Thanasoula; Fotios Tekos; Robin Mesnage; Demetrios Kouretas; Aristidis Tsatsakis Journal: Int J Environ Res Public Health Date: 2020-06-10 Impact factor: 3.390